Skip to main content
. 2022 Feb;13(1):426–437. doi: 10.21037/jgo-21-274

Figure 2.

Figure 2

Mechanism of action of anti-vascular endothelial growth factor monoclonal antibodies. The figure is reused from the article below Gao F, Yang C. Anti-VEGF/VEGFR2 Monoclonal Antibodies and their Combinations with PD-1/PD-L1 Inhibitors in Clinic. Curr Cancer Drug Targets 2020;20:3-18.